APO Research, Inc.

APO RESEARCH · REPORT

Micafungin Sodium Drug

Selected research

Industry Growth & Trends

Global Micafungin Sodium Drug Industry Growth and Trends Forecast to 2032

Market perspective

The global Micafungin Sodium Drug market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Micafungin Sodium Drug is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Micafungin Sodium Drug is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Micafungin Sodium Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Micafungin Sodium Drug include Apotex, Endo International, Hikma, Xellia Pharmaceuticals, Astellas, Jiangsu Hansoh Pharmaceutical and Teva, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Micafungin Sodium Drug market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Micafungin Sodium Drug market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Micafungin Sodium Drug market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Micafungin Sodium Drug.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Micafungin Sodium Drug market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Micafungin Sodium Drug Market by Company

Apotex

Endo International

Hikma

Xellia Pharmaceuticals

Astellas

Jiangsu Hansoh Pharmaceutical

Teva

Micafungin Sodium Drug Segment by Type

50 mg Single-use Vial

100 mg Single-use Vial

Micafungin Sodium Drug Segment by Application

Respiratory Mycosis

Candidemia

Gastrointestinal Mycosis

Micafungin Sodium Drug Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Micafungin Sodium Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Micafungin Sodium Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Micafungin Sodium Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Micafungin Sodium Drug manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Micafungin Sodium Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of 50 mg Single-use Vial Table 2. Major Company of 100 mg Single-use Vial Table 3. Global Micafungin Sodium Drug Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Micafungin Sodium Drug Sales by Type (2021-2026) & (K Units) Table 5. Global Micafungin Sodium Drug Sales Market Share in Volume by Type (2021-2026) Table 6. Global Micafungin Sodium Drug Sales by Type (2021-2026) & (US$ Million) Table 7. Global Micafungin Sodium Drug Sales Market Share in Value by Type (2021-2026) Table 8. Global Micafungin Sodium Drug Price by Type (2021-2026) & (US$/Unit) Table 9. Global Micafungin Sodium Drug Sales by Type (2027-2032) & (K Units) Table 10. Global Micafungin Sodium Drug Sales Market Share in Volume by Type (2027-2032) Table 11. Global Micafungin Sodium Drug Sales by Type (2027-2032) & (US$ Million) Table 12. Global Micafungin Sodium Drug Sales Market Share in Value by Type (2027-2032) Table 13. Global Micafungin Sodium Drug Price by Type (2027-2032) & (US$/Unit) Table 14. North America Micafungin Sodium Drug Sales by Type (2021-2026) & (K Units) Table 15. North America Micafungin Sodium Drug Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Micafungin Sodium Drug Sales by Type (2021-2026) & (K Units) Table 17. Europe Micafungin Sodium Drug Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Micafungin Sodium Drug Sales by Type (2021-2026) & (K Units) Table 19. Asia-Pacific Micafungin Sodium Drug Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Micafungin Sodium Drug Sales by Type (2021-2026) & (K Units) Table 21. Latin America Micafungin Sodium Drug Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Micafungin Sodium Drug Sales by Type (2021-2026) & (K Units) Table 23. Middle East and Africa Micafungin Sodium Drug Sales by Type (2021-2026) & (US$ Million) Table 24. Micafungin Sodium Drug Industry Trends Table 25. Micafungin Sodium Drug Industry Drivers Table 26. Micafungin Sodium Drug Industry Opportunities and Challenges Table 27. Micafungin Sodium Drug Industry Restraints Table 28. Global Micafungin Sodium Drug Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Micafungin Sodium Drug Revenue Market Share by Company (2021-2026) Table 30. Global Micafungin Sodium Drug Sales by Company (2021-2026) & (K Units) Table 31. Global Micafungin Sodium Drug Sales Share by Company (2021-2026) Table 32. Global Micafungin Sodium Drug Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global Micafungin Sodium Drug Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Micafungin Sodium Drug Major Company Production Sites and Headquarters Table 35. Global Micafungin Sodium Drug Company, Product Type & Application Table 36. Global Micafungin Sodium Drug Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Micafungin Sodium Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Micafungin Sodium Drug Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Micafungin Sodium Drug Sales by Region (2021-2026) & (K Units) Table 41. Global Micafungin Sodium Drug Sales Market Share in Volume by Region (2021-2026) Table 42. Global Micafungin Sodium Drug Sales by Region (2021-2026) & (US$ Million) Table 43. Global Micafungin Sodium Drug Sales Market Share in Value by Region (2021-2026) Table 44. Global Micafungin Sodium Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global Micafungin Sodium Drug Sales by Region (2027-2032) & (K Units) Table 46. Global Micafungin Sodium Drug Sales Market Share in Volume by Region (2027-2032) Table 47. Global Micafungin Sodium Drug Sales by Region (2027-2032) & (US$ Million) Table 48. Global Micafungin Sodium Drug Sales Market Share in Value by Region (2027-2032) Table 49. Global Micafungin Sodium Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global Micafungin Sodium Drug Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Micafungin Sodium Drug Sales by Application (2021-2026) & (K Units) Table 52. Global Micafungin Sodium Drug Sales Market Share in Volume by Application (2021-2026) Table 53. Global Micafungin Sodium Drug Sales by Application (2021-2026) & (US$ Million) Table 54. Global Micafungin Sodium Drug Sales Market Share in Value by Application (2021-2026) Table 55. Global Micafungin Sodium Drug Price by Application (2021-2026) & (US$/Unit) Table 56. Global Micafungin Sodium Drug Sales by Application (2027-2032) & (K Units) Table 57. Global Micafungin Sodium Drug Sales Market Share in Volume by Application (2027-2032) Table 58. Global Micafungin Sodium Drug Sales by Application (2027-2032) & (US$ Million) Table 59. Global Micafungin Sodium Drug Sales Market Share in Value by Application (2027-2032) Table 60. Global Micafungin Sodium Drug Price by Application (2027-2032) & (US$/Unit) Table 61. North America Micafungin Sodium Drug Sales by Application (2021-2026) & (K Units) Table 62. North America Micafungin Sodium Drug Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Micafungin Sodium Drug Sales by Application (2021-2026) & (K Units) Table 64. Europe Micafungin Sodium Drug Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Micafungin Sodium Drug Sales by Application (2021-2026) & (K Units) Table 66. Asia-Pacific Micafungin Sodium Drug Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Micafungin Sodium Drug Sales by Application (2021-2026) & (K Units) Table 68. Latin America Micafungin Sodium Drug Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Micafungin Sodium Drug Sales by Application (2021-2026) & (K Units) Table 70. Middle East and Africa Micafungin Sodium Drug Sales by Application (2021-2026) & (US$ Million) Table 71. Apotex Company Information Table 72. Apotex Business Overview Table 73. Apotex Micafungin Sodium Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Apotex Micafungin Sodium Drug Product Portfolio Table 75. Apotex Recent Development Table 76. Endo International Company Information Table 77. Endo International Business Overview Table 78. Endo International Micafungin Sodium Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Endo International Micafungin Sodium Drug Product Portfolio Table 80. Endo International Recent Development Table 81. Hikma Company Information Table 82. Hikma Business Overview Table 83. Hikma Micafungin Sodium Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Hikma Micafungin Sodium Drug Product Portfolio Table 85. Hikma Recent Development Table 86. Xellia Pharmaceuticals Company Information Table 87. Xellia Pharmaceuticals Business Overview Table 88. Xellia Pharmaceuticals Micafungin Sodium Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Xellia Pharmaceuticals Micafungin Sodium Drug Product Portfolio Table 90. Xellia Pharmaceuticals Recent Development Table 91. Astellas Company Information Table 92. Astellas Business Overview Table 93. Astellas Micafungin Sodium Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Astellas Micafungin Sodium Drug Product Portfolio Table 95. Astellas Recent Development Table 96. Jiangsu Hansoh Pharmaceutical Company Information Table 97. Jiangsu Hansoh Pharmaceutical Business Overview Table 98. Jiangsu Hansoh Pharmaceutical Micafungin Sodium Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Jiangsu Hansoh Pharmaceutical Micafungin Sodium Drug Product Portfolio Table 100. Jiangsu Hansoh Pharmaceutical Recent Development Table 101. Teva Company Information Table 102. Teva Business Overview Table 103. Teva Micafungin Sodium Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Teva Micafungin Sodium Drug Product Portfolio Table 105. Teva Recent Development Table 106. North America Micafungin Sodium Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 107. North America Micafungin Sodium Drug Sales by Country (2021-2026) & (K Units) Table 108. North America Micafungin Sodium Drug Sales Market Share by Country (2021-2026) Table 109. North America Micafungin Sodium Drug Sales Forecast by Country (2027-2032) & (K Units) Table 110. North America Micafungin Sodium Drug Sales Market Share Forecast by Country (2027-2032) Table 111. North America Micafungin Sodium Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 112. North America Micafungin Sodium Drug Market Size by Country (2021-2026) & (US$ Million) Table 113. North America Micafungin Sodium Drug Market Share by Country (2021-2026) Table 114. North America Micafungin Sodium Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 115. North America Micafungin Sodium Drug Market Share Forecast by Country (2027-2032) Table 116. Europe Micafungin Sodium Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 117. Europe Micafungin Sodium Drug Sales by Country (2021-2026) & (K Units) Table 118. Europe Micafungin Sodium Drug Sales Market Share by Country (2021-2026) Table 119. Europe Micafungin Sodium Drug Sales Forecast by Country (2027-2032) & (K Units) Table 120. Europe Micafungin Sodium Drug Sales Market Share Forecast by Country (2027-2032) Table 121. Europe Micafungin Sodium Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 122. Europe Micafungin Sodium Drug Market Size by Country (2021-2026) & (US$ Million) Table 123. Europe Micafungin Sodium Drug Market Share by Country (2021-2026) Table 124. Europe Micafungin Sodium Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 125. Europe Micafungin Sodium Drug Market Share Forecast by Country (2027-2032) Table 126. Asia-Pacific Micafungin Sodium Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 127. Asia-Pacific Micafungin Sodium Drug Sales by Country (2021-2026) & (K Units) Table 128. Asia-Pacific Micafungin Sodium Drug Sales Market Share by Country (2021-2026) Table 129. Asia-Pacific Micafungin Sodium Drug Sales Forecast by Country (2027-2032) & (K Units) Table 130. Asia-Pacific Micafungin Sodium Drug Sales Market Share Forecast by Country (2027-2032) Table 131. Asia-Pacific Micafungin Sodium Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 132. Asia-Pacific Micafungin Sodium Drug Market Size by Country (2021-2026) & (US$ Million) Table 133. Asia-Pacific Micafungin Sodium Drug Market Share by Country (2021-2026) Table 134. Asia-Pacific Micafungin Sodium Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 135. Asia-Pacific Micafungin Sodium Drug Market Share Forecast by Country (2027-2032) Table 136. Latin America Micafungin Sodium Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 137. Latin America Micafungin Sodium Drug Sales by Country (2021-2026) & (K Units) Table 138. Latin America Micafungin Sodium Drug Sales Market Share by Country (2021-2026) Table 139. Latin America Micafungin Sodium Drug Sales Forecast by Country (2027-2032) & (K Units) Table 140. Latin America Micafungin Sodium Drug Sales Market Share Forecast by Country (2027-2032) Table 141. Latin America Micafungin Sodium Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 142. Latin America Micafungin Sodium Drug Market Size by Country (2021-2026) & (US$ Million) Table 143. Latin America Micafungin Sodium Drug Market Share by Country (2021-2026) Table 144. Latin America Micafungin Sodium Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 145. Latin America Micafungin Sodium Drug Market Share Forecast by Country (2027-2032) Table 146. Middle East and Africa Micafungin Sodium Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 147. Middle East and Africa Micafungin Sodium Drug Sales by Country (2021-2026) & (K Units) Table 148. Middle East and Africa Micafungin Sodium Drug Sales Market Share by Country (2021-2026) Table 149. Middle East and Africa Micafungin Sodium Drug Sales Forecast by Country (2027-2032) & (K Units) Table 150. Middle East and Africa Micafungin Sodium Drug Sales Market Share Forecast by Country (2027-2032) Table 151. Middle East and Africa Micafungin Sodium Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 152. Middle East and Africa Micafungin Sodium Drug Market Size by Country (2021-2026) & (US$ Million) Table 153. Middle East and Africa Micafungin Sodium Drug Market Share by Country (2021-2026) Table 154. Middle East and Africa Micafungin Sodium Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 155. Middle East and Africa Micafungin Sodium Drug Market Share Forecast by Country (2027-2032) Table 156. Key Raw Materials Table 157. Raw Materials Key Suppliers Table 158. Micafungin Sodium Drug Distributors List Table 159. Micafungin Sodium Drug Customers List Table 160. Research Programs/Design for This Report Table 161. Authors List of This Report Table 162. Secondary Sources Table 163. Primary Sources List of Figures Figure 1. Micafungin Sodium Drug Image Figure 2. Global Micafungin Sodium Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Micafungin Sodium Drug Market Size (2021-2032) & (US$ Million) Figure 4. Global Micafungin Sodium Drug Sales (2021-2032) & (K Units) Figure 5. 50 mg Single-use Vial Image Figure 6. Global 50 mg Single-use Vial Sales YoY Growth (2021-2032) & (K Units) Figure 7. 100 mg Single-use Vial Image Figure 8. Global 100 mg Single-use Vial Sales YoY Growth (2021-2032) & (K Units) Figure 9. Global Micafungin Sodium Drug Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Micafungin Sodium Drug Market Share by Type 2025 VS 2032 Figure 11. North America Micafungin Sodium Drug Sales Market Share in Volume by Type in 2025 Figure 12. North America Micafungin Sodium Drug Sales Market Share in Value by Type in 2025 Figure 13. Europe Micafungin Sodium Drug Sales Market Share in Volume by Type in 2025 Figure 14. Europe Micafungin Sodium Drug Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Micafungin Sodium Drug Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Micafungin Sodium Drug Sales Market Share in Value by Type in 2025 Figure 17. Latin America Micafungin Sodium Drug Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Micafungin Sodium Drug Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Micafungin Sodium Drug Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Micafungin Sodium Drug Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Micafungin Sodium Drug Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Respiratory Mycosis Image Figure 24. Global Respiratory Mycosis Sales YoY Growth (2021-2032) & (K Units) Figure 25. Candidemia Image Figure 26. Global Candidemia Sales YoY Growth (2021-2032) & (K Units) Figure 27. Gastrointestinal Mycosis Image Figure 28. Global Gastrointestinal Mycosis Sales YoY Growth (2021-2032) & (K Units) Figure 29. Global Micafungin Sodium Drug Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Micafungin Sodium Drug Market Share by Application 2025 VS 2032 Figure 31. North America Micafungin Sodium Drug Sales Market Share in Volume by Application in 2025 Figure 32. North America Micafungin Sodium Drug Sales Market Share in Value by Application in 2025 Figure 33. Europe Micafungin Sodium Drug Sales Market Share in Volume by Application in 2025 Figure 34. Europe Micafungin Sodium Drug Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Micafungin Sodium Drug Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Micafungin Sodium Drug Sales Market Share in Value by Application in 2025 Figure 37. Latin America Micafungin Sodium Drug Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Micafungin Sodium Drug Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Micafungin Sodium Drug Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Micafungin Sodium Drug Sales Market Share in Value by Application in 2025 Figure 41. North America Micafungin Sodium Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 42. North America Micafungin Sodium Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Micafungin Sodium Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Micafungin Sodium Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Micafungin Sodium Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. Europe Micafungin Sodium Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Micafungin Sodium Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Micafungin Sodium Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Micafungin Sodium Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Asia-Pacific Micafungin Sodium Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Micafungin Sodium Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Micafungin Sodium Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Micafungin Sodium Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Latin America Micafungin Sodium Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Micafungin Sodium Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Micafungin Sodium Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Micafungin Sodium Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Middle East and Africa Micafungin Sodium Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Micafungin Sodium Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Micafungin Sodium Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Micafungin Sodium Drug Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Micafungin Sodium Drug Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • 50 mg Single-use Vial
  • 100 mg Single-use Vial
Applications
  • Respiratory Mycosis
  • Candidemia
  • Gastrointestinal Mycosis
Companies covered
  • Apotex
  • Endo International
  • Hikma
  • Xellia Pharmaceuticals
  • Astellas
  • Jiangsu Hansoh Pharmaceutical
  • Teva

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Micafungin Sodium Drug Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Micafungin Sodium Drug Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Micafungin Sodium Drug Market by Type
  6. 1.3.1 50 mg Single-use Vial
  7. 1.3.2 100 mg Single-use Vial
  8. 1.4 Global Micafungin Sodium Drug Market Size by Type
  9. 1.4.1 Global Micafungin Sodium Drug Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Micafungin Sodium Drug Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Micafungin Sodium Drug Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Micafungin Sodium Drug Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Micafungin Sodium Drug Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Micafungin Sodium Drug Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Micafungin Sodium Drug Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Micafungin Sodium Drug Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Micafungin Sodium Drug Industry Trends
  2. 2.2 Micafungin Sodium Drug Industry Drivers
  3. 2.3 Micafungin Sodium Drug Industry Opportunities and Challenges
  4. 2.4 Micafungin Sodium Drug Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Micafungin Sodium Drug Revenue (2021-2026)
  2. 3.2 Global Top Players by Micafungin Sodium Drug Sales (2021-2026)
  3. 3.3 Global Top Players by Micafungin Sodium Drug Price (2021-2026)
  4. 3.4 Global Micafungin Sodium Drug Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Micafungin Sodium Drug Major Company Production Sites & Headquarters
  6. 3.6 Global Micafungin Sodium Drug Company, Product Type & Application
  7. 3.7 Global Micafungin Sodium Drug Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Micafungin Sodium Drug Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Micafungin Sodium Drug Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Micafungin Sodium Drug Tier 1, Tier 2, and Tier 3
4 Micafungin Sodium Drug Regional Status and Outlook
  1. 4.1 Global Micafungin Sodium Drug Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Micafungin Sodium Drug Historic Market Size by Region
  3. 4.2.1 Global Micafungin Sodium Drug Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Micafungin Sodium Drug Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Micafungin Sodium Drug Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Micafungin Sodium Drug Forecasted Market Size by Region
  7. 4.3.1 Global Micafungin Sodium Drug Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Micafungin Sodium Drug Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Micafungin Sodium Drug Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Micafungin Sodium Drug by Application
  1. 5.1 Micafungin Sodium Drug Market by Application
  2. 5.1.1 Respiratory Mycosis
  3. 5.1.2 Candidemia
  4. 5.1.3 Gastrointestinal Mycosis
  5. 5.2 Global Micafungin Sodium Drug Market Size by Application
  6. 5.2.1 Global Micafungin Sodium Drug Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Micafungin Sodium Drug Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Micafungin Sodium Drug Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Micafungin Sodium Drug Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Micafungin Sodium Drug Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Micafungin Sodium Drug Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Micafungin Sodium Drug Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Micafungin Sodium Drug Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Apotex
  2. 6.1.1 Apotex Company Information
  3. 6.1.2 Apotex Business Overview
  4. 6.1.3 Apotex Micafungin Sodium Drug Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Apotex Micafungin Sodium Drug Product Portfolio
  6. 6.1.5 Apotex Recent Developments
  7. 6.2 Endo International
  8. 6.2.1 Endo International Company Information
  9. 6.2.2 Endo International Business Overview
  10. 6.2.3 Endo International Micafungin Sodium Drug Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Endo International Micafungin Sodium Drug Product Portfolio
  12. 6.2.5 Endo International Recent Developments
  13. 6.3 Hikma
  14. 6.3.1 Hikma Company Information
  15. 6.3.2 Hikma Business Overview
  16. 6.3.3 Hikma Micafungin Sodium Drug Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Hikma Micafungin Sodium Drug Product Portfolio
  18. 6.3.5 Hikma Recent Developments
  19. 6.4 Xellia Pharmaceuticals
  20. 6.4.1 Xellia Pharmaceuticals Company Information
  21. 6.4.2 Xellia Pharmaceuticals Business Overview
  22. 6.4.3 Xellia Pharmaceuticals Micafungin Sodium Drug Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Xellia Pharmaceuticals Micafungin Sodium Drug Product Portfolio
  24. 6.4.5 Xellia Pharmaceuticals Recent Developments
  25. 6.5 Astellas
  26. 6.5.1 Astellas Company Information
  27. 6.5.2 Astellas Business Overview
  28. 6.5.3 Astellas Micafungin Sodium Drug Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Astellas Micafungin Sodium Drug Product Portfolio
  30. 6.5.5 Astellas Recent Developments
  31. 6.6 Jiangsu Hansoh Pharmaceutical
  32. 6.6.1 Jiangsu Hansoh Pharmaceutical Company Information
  33. 6.6.2 Jiangsu Hansoh Pharmaceutical Business Overview
  34. 6.6.3 Jiangsu Hansoh Pharmaceutical Micafungin Sodium Drug Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Jiangsu Hansoh Pharmaceutical Micafungin Sodium Drug Product Portfolio
  36. 6.6.5 Jiangsu Hansoh Pharmaceutical Recent Developments
  37. 6.7 Teva
  38. 6.7.1 Teva Company Information
  39. 6.7.2 Teva Business Overview
  40. 6.7.3 Teva Micafungin Sodium Drug Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Teva Micafungin Sodium Drug Product Portfolio
  42. 6.7.5 Teva Recent Developments
7 North America by Country
  1. 7.1 North America Micafungin Sodium Drug Sales by Country
  2. 7.1.1 North America Micafungin Sodium Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Micafungin Sodium Drug Sales by Country (2021-2026)
  4. 7.1.3 North America Micafungin Sodium Drug Sales Forecast by Country (2027-2032)
  5. 7.2 North America Micafungin Sodium Drug Market Size by Country
  6. 7.2.1 North America Micafungin Sodium Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Micafungin Sodium Drug Market Size by Country (2021-2026)
  8. 7.2.3 North America Micafungin Sodium Drug Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Micafungin Sodium Drug Sales by Country
  2. 8.1.1 Europe Micafungin Sodium Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Micafungin Sodium Drug Sales by Country (2021-2026)
  4. 8.1.3 Europe Micafungin Sodium Drug Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Micafungin Sodium Drug Market Size by Country
  6. 8.2.1 Europe Micafungin Sodium Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Micafungin Sodium Drug Market Size by Country (2021-2026)
  8. 8.2.3 Europe Micafungin Sodium Drug Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Micafungin Sodium Drug Sales by Country
  2. 9.1.1 Asia-Pacific Micafungin Sodium Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Micafungin Sodium Drug Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Micafungin Sodium Drug Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Micafungin Sodium Drug Market Size by Country
  6. 9.2.1 Asia-Pacific Micafungin Sodium Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Micafungin Sodium Drug Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Micafungin Sodium Drug Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Micafungin Sodium Drug Sales by Country
  2. 10.1.1 South America Micafungin Sodium Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Micafungin Sodium Drug Sales by Country (2021-2026)
  4. 10.1.3 South America Micafungin Sodium Drug Sales Forecast by Country (2027-2032)
  5. 10.2 South America Micafungin Sodium Drug Market Size by Country
  6. 10.2.1 South America Micafungin Sodium Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Micafungin Sodium Drug Market Size by Country (2021-2026)
  8. 10.2.3 South America Micafungin Sodium Drug Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Micafungin Sodium Drug Sales by Country
  2. 11.1.1 Middle East and Africa Micafungin Sodium Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Micafungin Sodium Drug Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Micafungin Sodium Drug Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Micafungin Sodium Drug Market Size by Country
  6. 11.2.1 Middle East and Africa Micafungin Sodium Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Micafungin Sodium Drug Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Micafungin Sodium Drug Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Micafungin Sodium Drug Value Chain Analysis
  2. 12.1.1 Micafungin Sodium Drug Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Micafungin Sodium Drug Production Mode & Process
  7. 12.2 Micafungin Sodium Drug Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Micafungin Sodium Drug Distributors
  10. 12.2.3 Micafungin Sodium Drug Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.